COX-2 and cancer: a new approach to an old problem.
Bakhle
Y S
YS
Leukocyte Biology, Division of Biomedical Sciences, Faculty of Medicine, Imperial College, London SW7 2AZ. y.bakhle@ic.ac.uk
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology*; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology*; D051546:Cyclooxygenase 2; D016021:Epidemiologic Studies; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism*; D008565:Membrane Proteins; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism*; D011453:Prostaglandins / Q000096:biosynthesis*; D018160:Receptors, Cytoplasmic and Nuclear / Q000187:drug effects*; D014157:Transcription Factors / Q000187:drug effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007527:Isoenzymes; D008565:Membrane Proteins; D011453:Prostaglandins; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D001241:Aspirin